SCHEMBL23584640

SCHEMBL23584640

C[C@@H]1O[C@H](CN2CCCC23CCN(C)CC3)[C@@H](O)[C@H]1O

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 8/20 0.50
▸ WDR77 Q9BQA1 7/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10069646 0.68 FUCA1 (0.33) —
SCHEMBL24923748 0.66 CHRM2 (0.34) PRMT5WDR77
SCHEMBL21146567 0.57 LGALS1 (0.48) —
SCHEMBL20805367 0.57 LGALS1 (0.48) —
SCHEMBL21621598 0.57 LGALS1 (0.48) —
SCHEMBL22174657 0.57 LGALS1 (0.48) —
SCHEMBL25090768 0.57 LGALS1 (0.48) —
SCHEMBL23844307 0.57 LGALS1 (0.48) —
SCHEMBL22330650 0.57 FUCA1 (0.39) —
SCHEMBL2600086 0.57 LGALS1 (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
Send feedback